AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 201 min read$CBRS

Feldman Andrew D. sold $5.9M of CBRS

Feldman Andrew D. (CEO, President) sold 26,644 shares of Cerebras Systems Inc. (CBRS) at an average of $222.22 ($214.85–$240.01, $5.92M total) across 26 trades on 2026-08-18.

Original reporting
SEC EDGAR · Feldman Andrew D.
Published Aug 20, 2026, 1:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 1:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
medium confidence
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishLow
01

Why it matters

The CEO's reduction of ownership may be interpreted as a lack of confidence, prompting short‑term selling pressure.

02

Market read

Insider sell of $5.9 M by the CEO is a material event for CBRS, offering a modest bearish signal for traders.

03

What to watch

Potential upcoming capital raise or strategic shift not disclosed; the sale may free cash for future initiatives.

Relevance 6/10Novelty 7/10Timing: post‑market filing on 2026‑08‑18

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources of corporate insider activity.

Company-level read

Ticker impact

$CBRSBearishMedium confidence
Context

CEO Andrew Feldman sold 26,644 shares for $5.9 M via a Form 4 filing, reducing his stake to 66,853 shares.

Expected impact

Modest short‑term price dip, likely 1‑2% decline if market reacts.

Evidence & confidence

A $5.9 M sale by the CEO is material but not large enough to trigger a sharp move; investors may view it as a neutral signal.

Market effects

Sector

Minimal impact on the AI‑hardware sector; peers unlikely to be affected.

Regional

U.S. market only; no broader regional effect.

Global

Low; the filing is company‑specific.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to fundamentals, so price may remain stable.

Key entities

  • company
    Cerebras Systems Inc.

    AI‑chip maker listed on Nasdaq (CBRS).

  • person
    Andrew D. Feldman

    CEO and President of Cerebras Systems.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CBRS insider trading history →

Related articles

OCT 6
$CBRSMed

Cerebras stock jumps 9%; Q3 sales guide sets a harder test

Cerebras Systems (CBRS) stock rose 9% after OpenAI's Sam Altman reaffirmed their partnership. The company's Q3 revenue guidance suggests 2.4% sequential growth. OpenAI committed to 750MW of capacity, with an option for 1.25GW. Cerebras reported $56.8M in OpenAI-related revenue in Q2, 31.5% of total GAAP revenue. The stock remains below its IPO price of $185.

techi.com2 min
OCT 5
$CBRSHigh

CBRS Stock Surges Over 6% in Monday Pre-Market: What's the Sam Altman Connection? - Cerebras Systems (NAS

Cerebras Systems (CBRS) shares rose 6.56% premarket after OpenAI CEO Sam Altman called it a 'close partner,' easing concerns. Analysts noted strong ties with OpenAI, despite Nvidia (NVDA) running its new model. Barclays' Tom O'Malley called the sell-off 'overdone,' while Paul Meeks upgraded CBRS to Buy with a $209 target, citing high AI demand. CBRS is down 52.45% YTD.

benzinga.com2 min
OCT 5
$CBRSMed

Mizuho reiterates Cerebras Systems stock rating on inference growth

Mizuho reiterated its Outperform rating and $300 price target for Cerebras Systems (CBRS), citing growth in fast inference workloads. The firm projects a $550B market by 2030, with CBRS trading near its 52-week low at $166.43. CBRS reported 91% revenue growth over the last year, and analysts have revised earnings upwards, though some suggest overvaluation. The company unveiled the CS-4 system, with improved performance and compute density, expected in Q3.

investing.com2 min